IP Library Granted Patent US 8,092,993
Granted Patent B2
US 8,092,993 · App. 12/338,806 · Granted Jan 10, 2012

Hydrogel thin film for use as a biosensor

Assignee: Nellcor Puritan Bennett LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,092,993
App. No.
12/338,806
Granted
Jan 10, 2012
Kind
B2
Abstract

The present disclosure provides a biosensor capable of producing an indicator response upon detection of the presence of certain metabolites in a biological sample. The biosensor includes a hydrogel that is functionalized with affinity molecules specific to markers for one or more pathogens. The biosensor also includes a detection system adapted to detect the binding the pathogen-specific markers with their corresponding affinity molecules.

Claims (30)

1. A biosensor for detecting a pathogen comprising:

a hydrogel functionalized with:

a first affinity molecule with binding specificity for a first pathogen specific marker;

a second affinity molecule with binding specificity for a second pathogen-specific marker; and

a third affinity molecule with binding specificity for a third pathogen-specific marker;

a first indicator capable of producing a first output upon binding of the first affinity molecule with the first pathogen-specific marker;

a second indicator capable of producing a second output upon binding of the second affinity molecule with the second pathogen-specific marker; and

a third indicator capable of producing a third output upon binding of the third affinity molecule with the third pathogen-specific marker, wherein at least one of the first, second, or third outputs comprises an electrical output.

2. The biosensor in claim 1 , wherein the biosensor comprises an adhesive configured to affix the biosensor to a patient.

3. The biosensor recited in claim 1 , wherein the first, second, and third pathogen-specific markers are metabolic products of the pathogen.

4. The biosensor recited in claim 1 , wherein at least one of the first, second, or third outputs comprises a change in electrical impedance of the hydrogel triggered by binding of the respective first, second, or third pathogen-specific marker.

5. The biosensor recited in claim 1 , wherein at least one of the first, second, or third pathogen-specific markers is specific to helicobacter pylori.

6. The biosensor recited in claim 1 , wherein the first, second, and third pathogen-specific markers are part of a secretome of the pathogen.

7. The biosensor recited in claim 6 , wherein the first, second, and third pathogen-specific markers are part of the secretome of Plasmodium falciparum.

8. The biosensor recited in claim 6 , wherein the first, second, and third pathogen-specific markers comprise proteins having the pexel/vacuolar transport signal.

9. The biosensor recited in claim 1 , wherein at least one of the first, second, or third affinity molecules is an antibody.

10. The biosensor recited in claim 1 , wherein the first affinity molecule is disposed on a first region of the hydrogel, the second affinity molecule is disposed on a second region of the hydrogel, and a third affinity molecule is disposed on a third region of the hydrogel.

11. The biosensor recited in claim 1 , wherein the hydrogel comprises 2-hydroxyethyl methacrylate or N-Isopropylacrylamide.

12. The biosensor recited in claim 1 , wherein the hydrogel comprises a mucoadhesive.

13. A system for detecting a pathogen comprising:

a hydrogel functionalized with:

a first affinity molecule with binding specificity for a first pathogen-specific marker;

a second affinity molecule with binding specificity for a second pathogen-specific marker; and

a third affinity molecule with binding specificity for a third pathogen-specific marker;

a first indicator capable of producing a first output upon binding of the first affinity molecule with the first pathogen-specific marker;

a second indicator capable of producing a second output upon binding of the second affinity molecule with the second pathogen-specific marker;

a third indicator capable of producing a third output upon binding of the third affinity molecule with the third pathogen-specific marker, wherein at least one of the first, second, or third outputs comprises an electrical output; and

a monitor operatively coupled to the first indicator, the second indicator, and the third indicator, wherein the monitor is configured to receive the first output, the second output, and the third output and perform an operation to determine if the pathogen is present in a biological sample.

14. The system recited in claim 13 , comprising an alarm that is adapted to be triggered upon detection of the pathogen.

15. The system recited in claim 13 , wherein the hydrogel is disposed on a surface of the biosensor adapted to directly contact a patient.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2012
From: NELLCOR PURITAN BENNETT LLC
To: COVIDIEN LP
Reel/Frame 029379/0532 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2009
From: CAMPBELL, SHANNON E.
To: NELLCOR PURITAN BENNETT LLC
Reel/Frame 022079/0427 →
Continuity (2)
Provisional Application 61009721 · Dec 31, 2007
Related Publication 20090170124A1 · Jul 2, 2009